Patents by Inventor Marc Garnick

Marc Garnick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating hormone associated conditions using a combination of LHRH antagonists and specific estrogen receptor modulators
    Publication number: 20070066536
    Abstract: Methods for treating hormone associated conditions, such as endometriosis, uterine leiomata, ovarian cancer, breast cancer, or vaginal bleeding, using LHRH antagonists and selective estrogen receptor modulators are disclosed. The methods include administering to a subject a combination of an LHRH antagonist and a selective estrogen receptor modulator. Pharmaceutical compositions and kits for use in the methods of the invention are also provided.
    Type: Application
    Filed: September 15, 2006
    Publication date: March 22, 2007
    Applicant: Praecis Pharmaceuticals, Inc.
    Inventor: Marc Garnick
  • Methods for treating FSH related conditions with GnRH antagonists
    Publication number: 20070015714
    Abstract: Methods for treating FSH related conditions, such as prostatic intraepithelial neoplasia, pedophilia, infertility, or vaginal bleeding, with GnRH antagonists are disclosed. The methods of the invention generally feature administering to a subject a GnRH antagonist suitable for in vivo administration and able to reduce both plasma FSH and LH levels in a subject, in an amount or in a formulation effective to reduce plasma FSH levels in the subject to a symptom alleviating level. In vitro fertilization and male contraceptive methods are also provided.
    Type: Application
    Filed: January 30, 2006
    Publication date: January 18, 2007
    Applicant: Praecis Pharmaceuticals, Inc.
    Inventors: Marc Garnick, Paul Martha, Christopher Molineaux, Alex DePaoli
  • Methods for treating long QT syndrome
    Publication number: 20050233970
    Abstract: The present invention provides compositions and methods for treating QT prolongation in a subject in need thereof. The method comprises the step of administering to the subject a therapeutically effective amount of an agent which increases the androgen level of the subject.
    Type: Application
    Filed: March 23, 2005
    Publication date: October 20, 2005
    Applicant: Praecis Pharmaceuticals, Inc.
    Inventor: Marc Garnick
  • Method for reducing cholesterol by co-administering M-CSF and conventional cholesterol reducing agents
    Patent number: 5340573
    Abstract: Methods are presented for improving the lipoprotein cholesterol profile of a mammal. Methods are also presented for removing atherosclerotic lesions from a mammal that has such lesions. The methods comprise administering to the mammal a therapeutic amount of an M-CSF protein in combination with a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: March 8, 1993
    Date of Patent: August 23, 1994
    Assignee: Genetics Institute, Inc.
    Inventor: Marc Garnick
  • Use of M-CSF to improve lipoprotein cholesterol profiles
    Patent number: 5021239
    Abstract: Methods are presented for improving the lipoprotein cholesterol profile of a mammal. Methods are also presented for removing atherosclerotic lesions from a mammal that has such lesions. The methods comprise administering to the mammal a therapeutic amount of an M-CSF protein in combination with a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: December 8, 1988
    Date of Patent: June 4, 1991
    Assignee: Genetics Institute, Inc.
    Inventor: Marc Garnick
  • Method for lowering cholesterol levels using GM-CSF
    Patent number: 5019381
    Abstract: Methods are presented for lowering levels of lipoprotein cholesterol, serum cholesterol and other lipids comprising the administration of M-CSF or GM-CSF.
    Type: Grant
    Filed: March 21, 1988
    Date of Patent: May 28, 1991
    Assignee: Genetics Institute, Inc.
    Inventor: Marc Garnick